{"Abstract": [0], "Many": [1], "types": [2, 140], "of": [3, 34, 53, 119, 141, 152, 175, 184, 202, 205, 216, 279, 291], "human": [4], "cells": [5, 62, 111, 142, 218], "self-destruct": [6], "to": [7, 65, 78, 99, 102, 124, 295], "maintain": [8], "biological": [9, 29], "homeostasis": [10], "and": [11, 71, 88, 97, 135, 143, 154, 173, 179, 181, 193, 212, 232, 241, 253, 257, 288], "defend": [12], "the": [13, 32, 51, 117, 120, 146, 149, 170, 182, 199, 210, 213, 220, 229, 277, 281, 289], "body": [14], "against": [15], "pathogenic": [16], "substances.": [17], "This": [18], "process,": [19], "called": [20], "regulated": [21, 113, 214], "cell": [22, 81, 191, 207], "death": [23, 114, 153, 208, 215], "(RCD),": [24], "is": [25], "important": [26], "for": [27, 50, 131, 270], "various": [28], "activities,": [30], "including": [31], "clearance": [33], "aberrant": [35], "cells.": [36], "Thus,": [37], "RCD": [38, 91, 187, 239, 263, 282, 293], "pathways": [39, 240], "represented": [40], "by": [41], "apoptosis": [42], "have": [43, 75, 93, 265], "increased": [44], "in": [45, 56, 145, 162, 219, 251, 254, 261], "importance": [46], "as": [47, 268], "a": [48], "target": [49], "development": [52], "cancer": [54, 80, 103, 133, 194, 246, 271, 285, 296], "medications": [55], "recent": [57], "years.": [58], "However,": [59], "because": [60], "tumor": [61, 110, 121, 159, 190, 206, 224], "show": [63], "avoidance": [64], "apoptosis,": [66], "which": [67, 262], "causes": [68], "treatment": [69, 297], "resistance": [70, 287], "recurrence,": [72], "numerous": [73], "studies": [74, 256], "been": [76, 94, 266], "devoted": [77], "alternative": [79], "mortality": [82], "processes,": [83], "namely": [84], "necroptosis,": [85, 176], "pyroptosis,": [86, 177], "ferroptosis,": [87, 178], "cuproptosis;": [89], "these": [90, 185], "modalities": [92, 188], "extensively": [95], "studied": [96], "shown": [98], "be": [100], "crucial": [101], "therapy": [104], "effectiveness.": [105], "Furthermore,": [106], "evidence": [107, 249], "suggests": [108], "that": [109, 222, 234], "undergoing": [112], "may": [115], "alter": [116], "immunogenicity": [118], "microenvironment": [122], "(TME)": [123], "some": [125], "extent,": [126], "rendering": [127], "it": [128, 197], "more": [129], "suitable": [130], "inhibiting": [132], "progression": [134], "metastasis.": [136, 195], "In": [137], "addition,": [138], "other": [139, 217], "components": [144], "TME": [147, 211, 221], "undergo": [148], "abovementioned": [150], "forms": [151, 204], "induce": [155, 235], "immune": [156], "attacks": [157], "on": [158, 189, 209, 245, 248, 284], "cells,": [160], "resulting": [161], "enhanced": [163], "antitumor": [164], "responses.": [165], "Hence,": [166], "this": [167], "review": [168], "discusses": [169], "molecular": [171], "processes": [172, 283], "features": [174], "cuproptosis": [180], "effects": [183, 201, 244], "novel": [186, 203, 238], "proliferation": [192], "Importantly,": [196], "introduces": [198], "complex": [200], "affect": [223], "biology.": [225], "It": [226], "also": [227, 275], "summarizes": [228], "potential": [230], "agents": [231], "nanoparticles": [233], "or": [236], "inhibit": [237], "their": [242], "therapeutic": [243], "based": [247], "from": [250], "vivo": [252], "vitro": [255], "reports": [258], "clinical": [259], "trials": [260], "inducers": [264], "evaluated": [267], "treatments": [269], "patients.": [272], "Lastly,": [273], "we": [274], "summarized": [276], "impact": [278], "modulating": [280], "drug": [286], "advantages": [290], "adding": [292], "modulators": [294], "over": [298], "conventional": [299], "treatments.": [300]}